(iStock)

I share the concerns spotlighted in the Jan. 30 front-page article “Hope for Alzheimer’s patients, in unequal doses.”

The Davos Alzheimer’s Collaborative is working on a global scale to address disparities in Alzheimer’s research. We’re building a longitudinal research cohort of 1 million people who reflect the disease in all its diversity so we can better understand the heterogeneity of Alzheimer’s and accelerate the development of precision medicine.